欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NL/H/5565/001
药品名称
Ciprofloxacina Aurobindo
活性成分
Ciprofloxacin hydrochloride 250.0 mg
剂型
Film-coated tablet
上市许可持有人
Aurobindo Pharma (Portugal), Unipessoal, Lda.
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
Belgium (BE)
Ciprofloxacine AB 250mg filmomhulde tabletten, comprimés pelliculés, Filmtabletten
Luxembourg (LU)
Spain (ES)
许可日期
2015/06/17
最近更新日期
2024/10/15
药物ATC编码
J01MA02 ciprofloxacin
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final PL
|
Final common_pl
Date of last change:2025/02/18
Final SPC
|
Final common_spc
Date of last change:2025/02/18
Final Product Information
|
Clean_Ciprofloxacin Aurobindo film_coated tablets_Lab
Date of last change:2024/09/06
Final Product Information
|
Clean_Ciprofloxacin Aurobindo film_coated tablets_PIL
Date of last change:2024/09/06
Final Product Information
|
Clean_Ciprofloxacin Aurobindo film_coated tablets_SPC
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase